◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

YUBO INTERNATIONAL BIOTECH LTD

CIK: 895464 SIC: 3845
$-18.00
Revenue
$-1.33M
Net Income
-
Gross Margin
-
Op. Margin
$-2.39M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 13 of 44 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue - - - $-18.00 - - $3.49K $22.29K $428.51K $1.43K $156.62K $66.52K $14.58K
Revenue Growth % (YoY) nan% nan% -100.0% -100.1% -100.0% -100.0% -97.8% -66.5% 2839.0% nan% nan% nan% nan%
Cost of Revenue - - - $-5.00 - - $827.00 $4.22K $84.43K $545.00 $98.92K $37.59K $4.98K
+ Gross Profit - - - $-13.00 - - $2.66K $18.06K $344.08K $885.00 $57.69K $28.93K $9.60K
Gross Margin % nan% nan% nan% 72.2% nan% nan% 76.3% 81.0% 80.3% 61.9% 36.8% 43.5% 65.8%
Operating Expenses $310.13K $249.70K $467.30K $357.29K $532.76K $470.44K $412.08K $535.38K $337.66K $368.16K $374.22K $-74.55K $247.87K
+ Operating Income $-310.13K $-249.70K $-467.30K $-357.30K $-532.76K $-470.44K $-409.42K $-517.32K $6.42K $-367.28K $-316.53K $103.48K $-238.27K
Operating Margin % nan% nan% nan% 1984988.9% nan% nan% -11738.0% -2321.3% 1.5% -25683.6% -202.1% 155.6% -1634.2%
Interest Expense $18.00 $23.00 - - $49.00 $17.00 $84.00 - $130.00 $51.00 $135.00 - -
Other Income/Expense $-18.00 $-23.00 $-19.00 $4.41K $-88.29K $-127.91K $-84.00 $-61.00 $-130.00 $-51.00 $-135.00 $127.00 $174.00
Income Before Tax $-310.15K $-249.72K $-467.32K $-352.89K $-621.05K $-598.35K $-409.50K $-517.38K $6.29K $-367.33K $-316.67K $103.61K -
Income Tax Expense - - - - - - - - - - - - -
+ Net Income $-310.15K $-230.33K $-435.63K $-352.89K $-621.05K $-598.35K $-409.50K $-517.38K $6.29K $-367.33K $-316.67K $103.61K $-238.10K
Net Margin % nan% nan% nan% 1960477.8% nan% nan% -11740.4% -2321.6% 1.5% -25687.2% -202.2% 155.8% -1633.0%
Diluted EPS 0.00 0.00 0.00 -0.01 -0.01 nan nan -0.09 nan nan nan nan nan
Diluted Shares Outstanding 147.9M 119.8M 119.8M - 119.8M - - -107.8M - - - - -
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents - - - - - - - - - - - - $89.97K
Accounts Receivable $114.29K $118.01K $146.69K $164.98K $218.01K $210.59K $114.72K $79.65K $48.51K $49.40K $58.22K $51.93K $48.46K
Inventory $37.89K $37.65K $37.21K $36.95K $6.57K $86.85K $211.80K $214.57K $209.75K $212.10K $224.63K $322.17K $130.55K
Total Current Assets $649.56K $659.10K $685.16K $682.75K $723.97K $761.40K $734.86K $725.24K $712.30K $700.59K $649.25K $750.01K $777.76K
Property Plant & Equipment $84.64K $126.01K $165.95K $205.91K $256.78K $293.25K $343.40K $375.21K $528.32K $523.78K $608.45K $616.65K $586.67K
Intangible Assets $43.24K $44.65K $47.51K $50.52K $56.07K $57.49K $61.24K $54.41K $55.59K $58.74K $64.93K $67.68K $68.50K
Total Assets $953.21K $1.05M $1.17M $1.53M $1.65M $1.73M $1.55M $1.67M $1.90M $1.96M $2.11M $2.35M $3.72M
Total Current Liabilities $2.56M $5.03M $4.78M $4.72M $4.49M $3.95M $3.52M $3.40M $2.87M $2.95M $2.67M $2.52M $2.97M
Total Liabilities $2.56M $5.03M $4.81M $4.83M $4.70M $4.15M $3.61M $3.51M $3.00M $3.11M $2.95M $2.91M $4.38M
Retained Earnings $-7.48M $-7.33M $-7.10M $-6.66M $-6.37M $-5.79M $-5.26M $-4.89M $-4.37M $-4.37M $-4.01M $-3.69M $-3.79M
Total Stockholders Equity $-1.66M $-4.00M $-3.67M $-3.42M $-3.13M $-2.52M $-2.07M $-1.84M $-1.10M $-1.15M $-838.75K $-565.37K $-658.14K
Total Liabilities & Equity $953.21K $1.05M $1.17M $1.53M $1.65M $1.73M $1.55M $1.67M $1.90M $1.96M $2.11M $2.35M $3.72M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-310.15K $-230.33K $-435.63K $-352.89K $-621.05K $-598.35K $-409.50K $-517.38K $-677.70K $-367.33K $-316.67K $103.61K $-1.31M
Depreciation & Amortization $41.89K $83.01K $41.26K $39.17K $130.71K $84.71K $43.30K $103.36K $74.95K $27.88K $9.56K $1.96K $16.14K
Change in Receivables - - $-18.30K $-53.03K $138.36K $130.94K $35.07K $-31.14K $3.42K $2.53K $6.29K $3.47K $-113.50K
Change in Inventory - - $259.00 $-185.85K $8.23K $172.00 $-2.77K $-4.83K $112.43K $110.07K $-97.55K $191.62K $-33.75K
Operating Cash Flow $-714.05K $-354.99K $-392.05K $-932.71K $-405.02K $-312.40K $-120.39K $-558.35K $-180.62K $-185.59K $-32.67K $-20.34K $88.58K
Capital Expenditure - - $6.19K - - - $18.92K - - - - - -
Investing Cash Flow $79.90K $79.90K $-6.19K - $118.43K $81.96K $-30.01K - - - - - $-39.77K
Stock Repurchased - - - - - - - - - - - - $819.23K
Financing Cash Flow $473.92K $473.92K $277.78K $1.11M $297.76K $272.38K $97.98K $745.66K - - - - -
Net Change in Cash $3.91K $3.40K $2.76K $-1.02K $1.68K $1.34K $50.66K $1.06K $-12.93K $-12.92K $12.01K $-71.75K $62.45K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - - $3.49K
Cost of Revenue - - - $827.00
Gross Profit - - - $2.66K
Operating Expenses $310.13K $532.76K $902.23K $1.42M
Operating Income $-310.13K $-532.76K $-902.23K $-1.41M
Interest Expense $18.00 $49.00 $60.00 $52.00
Other Income/Expense $-18.00 $-88.29K $-60.00 $-216.28K
Income Before Tax $-310.15K $-621.05K $-902.29K $-1.63M
Income Tax Expense - - - -
Net Income $-310.15K $-621.05K $-902.29K $-1.63M
Diluted EPS 0.00 -0.01 -0.01 -0.01
Diluted Shares Outstanding $147.87M $119.82M $129.27M $119.82M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Accounts Receivable $114.29K $164.98K
Inventory $37.89K $36.95K
Total Current Assets $649.56K $682.75K
Property Plant & Equipment $84.64K $205.91K
Intangible Assets $43.24K $50.52K
Total Assets $953.21K $1.53M
Total Current Liabilities $2.56M $4.72M
Total Liabilities $2.56M $4.83M
Retained Earnings $-7.48M $-6.66M
Total Stockholders Equity $-1.66M $-3.42M
Total Liabilities & Equity $953.21K $1.53M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-310.15K $-621.05K $-902.29K $-1.63M
Depreciation & Amortization $41.89K $45.99K $124.90K $130.71K
Operating Cash Flow - - $-714.05K $-405.02K
Investing Cash Flow - - $79.90K $118.43K
Financing Cash Flow - - $473.92K $297.76K
Net Change in Cash - - $3.91K $1.68K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...